Market Tracker

07/28 12:26pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

27.92
Data as of 12:10pm ET
 +0.05 / +0.18%
Today’s Change
19.39
Today|||52-Week Range
31.04
+11.06%
Year-to-Date

Today’s Trading

Previous close27.87
Today’s open27.87
Day’s range27.60 - 28.02
Volume159,710
Average volume (3 months)616,596
Market cap$2.0B
Dividend yield--
Data as of 12:10pm ET, 07/28/2014

Growth & Valuation

Earnings growth (last year)+79.27%
Earnings growth (this year)+10.15%
Earnings growth (next 5 years)+31.11%
Revenue growth (last year)-12.07%
P/E ratio1,396.0
Price/Sales3.29
Price/Book2.40

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...-0.36-1.75%
IRWDIronwood Pharmaceuti...-0.38-2.47%
GWPHGW Pharmaceuticals P...-1.64-1.93%
MDCOMedicines Co-0.81-3.32%
Data as of 12:25pm ET, 07/28/2014

Financials

Next reporting dateAugust 6, 2014
EPS forecast (this quarter)$0.37
Annual revenue (last year)$511.5M
Annual profit (last year)$101.3M
Net profit margin19.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President &
Chief Executive Officer
George Frederick Wilkinson
Chief Financial Officer &
Senior VP-Finance
Bryan M. Reasons
Corporate headquarters
Hayward, California

Forecasts